Results 51 to 60 of about 409,669 (384)

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

open access: yes, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A.   +4 more
core   +1 more source

Variability of the Left Atrial Appendage in Human Hearts. [PDF]

open access: yesPLoS ONE, 2015
Atrial fibrillation increases the risk of thrombus formation. It is commonly responsible for cerebral stroke whereas less frequently for pulmonary embolism.
Rafał Kamiński   +8 more
doaj   +1 more source

The long‐term efficacy and safety of combining ablation and left atrial appendage closure: A systematic review and meta‐analysis

open access: yesCardiovascular Electrophysiology, 2021
Combined ablation and left atrial appendage closure (LAAC) is an alternative for atrial fibrillation patients with a high risk of stroke. However, the long‐term outcomes of this combined procedure remain elusive.
Feng Li   +4 more
semanticscholar   +1 more source

Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]

open access: yes, 2017
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S.   +5 more
core   +2 more sources

The year in cardiology: arrhythmias and pacing. [PDF]

open access: yes, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H   +4 more
core   +4 more sources

Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade [PDF]

open access: yes, 2003
<b>1.</b> 5-Hydroxytryptamine (5-HT) has been postulated to play a proarrhythmic role in the human atria via stimulation of 5-HT<sub>4</sub> receptors.
Andrew C Rankin   +32 more
core   +2 more sources

Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2021
Atrial fibrillation is one of the most common cardiovascular disorders encountered by clinicians in clinical practice. Patients with atrial fibrillation are at risk of cerebrovascular and systemic embolic events, which may be attenuated by commencement ...
Hashrul N. Rashid, Jamie Layland
doaj  

THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Some aspects of prevention of thromboembolic events in patients with atrial fibrillation, in particular, the use of implantable left atrial appendage occluding devices are discussed.
K. V. Davtyan   +3 more
doaj   +3 more sources

Surgical clip closure of the left atrial appendage

open access: yesCardiovascular Electrophysiology, 2021
Atrial fibrillation (AF) is the most common atrial arrhythmia, but it is not a benign disease. AF is an important risk factor for thromboembolic events, causing significant morbidity and mortality.
F. Rosati   +4 more
semanticscholar   +1 more source

Improved outcomes in CABG patients with atrial fibrillation associated with surgical left atrial appendage exclusion

open access: yesJournal of cardiac surgery, 2021
We sought to determine the impact of left atrial appendage clip exclusion (LAACE) on coronary artery bypass grafting (CABG) outcomes among patients with pre‐existing atrial fibrillation (AF).
E. Soltesz   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy